To test this hypothesis, we analyzed the cytolytic activity of OT-1 splenocytes against a melanoma cell line expressing the full-length OVA protein (B16F10-OVA), which was shown to be selectively targeted by OT-1 CD8+ T cells [41] (Fig. 6C). Here, CD8A is linked to melanoma.